DGKA
DGKA (diacylglycerol kinase alpha, also known as DGK-alpha, DAGK or DAGK1) is a cytosolic lipid kinase that converts diacylglycerol into phosphatidic acid. In doing so it regulates the levels of two bioactive lipids that act as second messengers. Browse Assay Genie's current range of DGKA research reagents below, or read on for the biology behind the target.
DGKA is a diacylglycerol kinase that phosphorylates diacylglycerol (DAG) to give phosphatidic acid (PA), adjusting the relative levels of these two lipids. Because DAG and PA engage different cellular targets and have opposite effects in many biological processes, the enzyme is described as a central switch between the signalling pathways that each second messenger activates. DGKA also contributes to the biosynthesis of complex lipids.
The enzyme is not limited to DAG. In vitro, DGK-alpha can phosphorylate 1-alkyl-2-acylglycerol as efficiently as diacylglycerol, provided the substrate carries an arachidonoyl group. It is also involved in producing alkyl-lysophosphatidic acid, another bioactive lipid, through phosphorylation of 1-alkyl-2-acetyl glycerol. According to the NCBI Gene summary, it acts as a modulator that competes with protein kinase C for diacylglycerol in intracellular signalling, and it has a role in the resynthesis of phosphatidylinositols.
The DGKA gene encodes a member of the eukaryotic diacylglycerol kinase family, which HGNC places in the EF-hand domain containing and diacylglycerol kinase gene groups. The protein localises to the cytosol, and several transcript variants encoding different isoforms have been reported. Earlier names for the gene include diacylglycerol kinase, alpha (80kD), and mouse and rat each carry an orthologous Dgka gene, which allows the protein to be studied in rodent models.
DGKA sets the balance between diacylglycerol and phosphatidic acid, making it a key node for studying signalling driven by these two lipids.
By competing with protein kinase C for diacylglycerol, DGKA is a useful subject for work on how DAG availability shapes intracellular signalling.
DGKA contributes to the resynthesis of phosphatidylinositols and to the biosynthesis of complex lipids, relevant to studies of lipid metabolism.
DGKA is involved in making alkyl-lysophosphatidic acid, supporting research into the generation and turnover of bioactive lipids.
DGKA phosphorylates diacylglycerol to produce phosphatidic acid, controlling the levels of both lipids and acting as a switch between the signalling pathways they activate. It also contributes to complex lipid biosynthesis and to alkyl-lysophosphatidic acid production.
DGKA is also called DGK-alpha, DAGK and DAGK1. Earlier HGNC names were diacylglycerol kinase, alpha (80kD) and diacylglycerol kinase, alpha 80kDa. The NCBI Gene summary notes that several transcript variants encode different isoforms.
Yes. Mouse and rat both have an orthologous gene named Dgka. The protein belongs to the eukaryotic diacylglycerol kinase family, so it is conserved beyond humans; check the datasheet of any product for its validated reactivity.
Other diacylglycerol kinases and lipid-signalling targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P23743; product specifications from Assay Genie datasheets.